AFMD (Affimed NV) Bozor qiymatining balans qiymatiga nisbati

affimed.com (AFMD) kompaniyasining rasmiy ramzlari

GURU.Markets grafigidagi kunlik narx harakatlaridagi joriy narxning buki koeffitsiyenti Affimed kompaniyasining bozor qiymatini namoyish etadi, bunda 0.15 ushbu ko'rsatkichning joriy qiymatini ko'rsatadi. Firmaning kapitali saraton terapiyasi uchun immun aktivatorlarini yaratish va hamkorlik to'lovlariga asoslangan. Biroq, sinovlarning muvaffaqiyatsiz tugash xavfi va tadqiqot va ishlanmalar (R&D) xarajatlari marjalarni pasaytirmoqda. Rahbariyat hozirda xarajatlarni qisqartirib, dasturlarni cheklangan budjetga moslashtirmoqda.

AFMD affimed.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 24.05.2025 oraligʻida

Affimed (AFMD) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi affimed.com|AFMD - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Affimed Therapeutics|AFMD - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Affimed|AFMD - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati affimed.com|AFMD - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Affimed|AFMD - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati affimed.com|AFMD - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Affimed Therapeutics
Kompaniyaning dastlabki tahlili:Affimed NV - AFMD
affimed.com original mahsuloti

Uzoq muddatli kapital moddiy aktivlarga nisbatan haddan tashqari to'lovlar ustidan qat'iy nazoratni talab qiladi. Saratonga qarshi immun aktivatsiyaning noyob usullarini ishlab chiquvchi Affimed (AFMD) uchun intellektual mulkning baholanishi juda muhimdir. Kompaniyaning P/B koeffitsiyenti orqali baholash tarixi bozor qiymatini sof aktivlar bilan solishtiradi. Birga solishtirganda koeffitsiyentning birdan oshishi terapiyaning kelgusidagi muvaffaqiyatiga bozor ishonchini ko'rsatadi, biroq eng yuqori qiymatlar korreksiya xavfining ortganidan dalolat beradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati argenx SE|BNTX (biontech.de) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Astria Therapeutics (ATXS)|engene.com (ENGN) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati RAPT Therapeutics RAPT|Sof aktivlarga nisbatan bozor kapitallashuvi Aerovate|ACRS (Aclaris) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi KYTX (Kyverna Therapeutics, Inc)|Tiziana Life Sciences - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati cabalettabio.com CABA|VTYX (Ventyx Biosciences, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|THTX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Avalo Therapeutics Inc.|Eledon Pharmaceuticals, Inc (ELDN) - Kapitallashuvning balans qiymatiga nisbati|AGEN (Agenus) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati climbbio.com|ZURA - Bozor kapitallashuvining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ATYR (aTyr Pharma Inc)|Adagene Inc. - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati ImageneBio IMA|Shattuck Therapeutics (STTK) - Bozor kapitallashuvining balans qiymatiga nisbati|EQ: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati connectbiopharm.com (CNTB)|Immunic (IMUX) - Sof aktivlarga nisbatan bozor kapitallashuvi|ATRA - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati InflaRx GmbH|Bozor kapitallashuvining balans qiymatiga nisbati XFOR|Bozor kapitallashuvining balans qiymatiga nisbati ACET (adicetbio.com)|Bozor qiymatining balans qiymatiga nisbati Celularity|INmune Bio Inc - Balans qiymatiga nisbatan bozor qiymati|BRNS: Bozor qiymatining balans qiymatiga nisbati|KZR - Kapitallashuvning sof aktivlarga nisbati|SABS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati akaritx.com|ENLV - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Q32 Bio Corp|GOVX (GeoVax Labs Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi EDSA (Edesa Biotech Corp)|iBio, Inc. - Bozor qiymatining balans qiymatiga nisbati|Carisma Therapeutics Inc - Kapitallashuvning sof aktivlarga nisbati|XTLB: Bozor qiymatining balans qiymatiga nisbati|Bolt Biotherapeutics (BOLT) - Kapitallashuvning sof aktivlarga nisbati|HCWB: Kapitallashuvning sof aktivlarga nisbati|APVO (Aptevo Therapeutics Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati AIM ImmunoTech Inc. (AIM)|Kapitallashuvning balans qiymatiga nisbati Aditxt Corp|GRI Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XORTX Therapeutics Inc (XRTX)|Bozor kapitallashuvining balans qiymatiga nisbati HIND (ReShape Lifesciences)|Bozor kapitallashuvining balans qiymatiga nisbati Revelation Biosciences Corp REVB|Bozor kapitallashuvining balans qiymatiga nisbati Indaptus Therapeutics|SCNI - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati calcimedica.com (CALI)|Allakos (ALLK) - Sof aktivlarga nisbatan bozor kapitallashuvi|HOOK: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com (OCEA)|TCBP: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Third Harmonic Bio Inc. THRD